FACTORS INFLUENCING COMPLETE RESPONSE AND SURVIVAL IN PATIENTS WITH HEAD AND NECK-CANCER TREATED WITH PLATINUM-BASED INDUCTION CHEMOTHERAPY - A HELLENIC COOPERATIVE ONCOLOGY GROUP-STUDY

被引:15
作者
FOUNTZILAS, G
KOSMIDIS, P
BEER, M
SRIDHAR, KS
BANIS, K
VRITSIOS, A
DANIILIDIS, J
机构
[1] METAXA CANC HOSP, PIRAEUS, GREECE
[2] HECOG OFF, ATHENS, GREECE
[3] SYLVESTER COMPREHENS CANC CTR, MIAMI, FL USA
[4] VET ADM MED CTR, MIAMI, FL USA
关键词
HEAD AND NECK CANCER; INDUCTION CHEMOTHERAPY; PROGNOSTIC FACTORS;
D O I
10.1093/oxfordjournals.annonc.a058260
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
One hundred fifteen consecutive patients with locally advanced carcinoma of the head and neck were treated between August 1984 and August 1989 with three cycles of either of two platinum-based induction chemotherapies, followed by local treatment. After the completion of chemotherapy 26 (23%) patients had complete responses (CR). Several pre-treatment characteristics were analyzed for a possible correlation to CR to induction chemotherapy and to survival. The following variables were closely interrelated: sex, history of smoking, alcohol abuse, histologic type, tumor site and grade. Tumor stage and negative history of smoking were correlated with CR. The variables which were individually correlated with survival were keratinization, CR to chemotherapy, alcohol abuse, histologic type, site and grade of the primary tumor, serum albumin level and tumor stage. A regression analysis after Cox's model to identify a limited set of predictors selected CR, serum albumin, tumor grade, performance status and nodal status as the most significant; when analyzing the data without the time-dependent variable CR, the factors selected by the model were serum albumin, tumor grade, performance status and tumor stage. In conclusion, serum albumin level, tumor grade, performance status and tumor stage prior to treatment can be used to define risk classes in our patient population.
引用
收藏
页码:553 / 558
页数:6
相关论文
共 49 条
  • [1] ALKOURAINY K, 1987, CANCER, V59, P233, DOI 10.1002/1097-0142(19870115)59:2<233::AID-CNCR2820590210>3.0.CO
  • [2] 2-X
  • [3] ALSARRAF M, 1987, ADJUVANT THERAPY CAN, V5, P89
  • [4] AMER MH, 1979, CANCER, V43, P2202, DOI 10.1002/1097-0142(197906)43:6<2202::AID-CNCR2820430607>3.0.CO
  • [5] 2-J
  • [6] [Anonymous], 1987, CANCER-AM CANCER SOC, V60, P301
  • [7] COGNETTI F, 1988, CANCER-AM CANCER SOC, V62, P251, DOI 10.1002/1097-0142(19880715)62:2<251::AID-CNCR2820620205>3.0.CO
  • [8] 2-J
  • [9] PROGNOSTIC FACTORS FOR CHEMOTHERAPY RESPONSE AND SURVIVAL USING COMBINATION CHEMOTHERAPY AS INITIAL TREATMENT OF ADVANCED HEAD AND NECK SQUAMOUS-CELL CANCER
    COGNETTI, F
    PINNARO, P
    RUGGERI, EM
    CARLINI, P
    PERRINO, A
    IMPIOMBATO, FA
    CALABRESI, F
    CHILELLI, MG
    GIANNARELLI, D
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (07) : 829 - 837
  • [10] Cox D.R., 1989, ANAL BINARY DATA, V32